Ransom Advisory, LTD Moderna, Inc. Transaction History
Ransom Advisory, LTD
- $202 Billion
- Q1 2025
A detailed history of Ransom Advisory, LTD transactions in Moderna, Inc. stock. As of the latest transaction made, Ransom Advisory, LTD holds 150 shares of MRNA stock, worth $4,198. This represents 0.0% of its overall portfolio holdings.
Number of Shares
150Holding current value
$4,198% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding MRNA
# of Institutions
872Shares Held
255MCall Options Held
23.9MPut Options Held
31.3M-
Vanguard Group Inc Valley Forge, PA40.4MShares$1.13 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$715 Million0.07% of portfolio
-
Baillie Gifford & CO24.9MShares$698 Million0.64% of portfolio
-
State Street Corp Boston, MA17.8MShares$498 Million0.02% of portfolio
-
Geode Capital Management, LLC Boston, MA7.46MShares$209 Million0.02% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $10.9B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...